Rocket Lab (NASDAQ: RKLB) shares climbed 11.51% to $59.18 during Monday’s regular trading session as investors prepared for the company’s third-quarter results after the market close. The advance extends Friday’s 15.39% rally, which took the shares to $53.07, and puts the earnings announcement in focus as investors look for an updated timetable for the delayed Neutron rocket.
Rocket Lab will release its Q3 2026 financial results on Monday, November 9, after the US market closes. The company scheduled its conference call for 5 p.m. ET (2 p.m. Pacific Time), or 22:00 UTC, according to its October 20 investor-relations announcement.
The financial expectations are relatively clear. Rocket Lab previously guided for revenue of $250 million to $265 million, with a non-GAAP gross margin of 35% to 37% and an adjusted EBITDA loss of $17 million to $23 million. The more significant question for the call may be whether CEO Peter Beck provides a more specific target for Neutron’s first launch, which has moved from its previous 2026 schedule into 2027.
RKLB Stock Extends Friday’s 15% Rally Ahead of Earnings
Yahoo Finance recorded Rocket Lab at $59.18, up $6.11 or 11.51%, at 11:26 a.m. ET on Monday. The shares had closed Friday at $53.07, gaining $7.08 or 15.39% during that session. The latest move represents a substantial recovery from Thursday’s $45.99 close, although the stock remains volatile following the October announcement that Neutron’s first flight would be delayed.
The upcoming report arrives after a record second quarter. Rocket Lab generated $234 million in Q2 revenue, up 62% year over year, while its contracted backlog reached $2.36 billion, an increase of 137%. The company also disclosed more than $1 billion in new launch and space systems contracts entered into during the third quarter up to the August 10 announcement.
Those figures provide a strong revenue baseline, but the market will also assess whether the company can maintain its growth while continuing to fund Neutron’s development and its wider infrastructure expansion.
Rocket Lab’s $250 Million to $265 Million Revenue Guide
Rocket Lab’s Q3 guidance calls for revenue between $250 million and $265 million, compared with the $234 million reported in the preceding quarter. The company also expects GAAP gross margins of 29% to 31%, non-GAAP gross margins of 35% to 37%, and an adjusted EBITDA loss between $17 million and $23 million.
Analyst revenue estimates are clustered around the midpoint of that range. Koyfin puts expected revenue at $257.18 million, while Fiscal AI gives approximately $257.3 million. Both figures are close to management’s $257.5 million guidance midpoint.
EPS estimates are less consistent. Koyfin shows an expected GAAP loss of $0.07 per share, while Fiscal AI lists a loss of $0.02. These are provider-specific estimates and should not be treated as directly comparable without checking their accounting and adjustment methodologies.
The revenue expectations imply growth of approximately 66% from the $155.08 million reported in the third quarter of 2025. However, revenue growth alone will not settle the investment debate. Investors will also be watching gross margins, operating expenses and the adjusted EBITDA loss to assess whether the expanding business is moving toward improved operating economics.
FinanceFeeds previously examined the company’s record second-quarter performance, growing backlog and third-quarter guidance in its analysis of Rocket Lab’s Q2 results and the Neutron and Iridium investment outlook.
Neutron’s First Launch Has Moved Into 2027
The Neutron timetable is likely to attract particular attention during the earnings call. Rocket Lab’s August 10 Q2 release said production of the first-stage tank remained aligned with a target delivery to the launch pad in the fourth quarter of 2026. That was a pad-delivery milestone, not a confirmed maiden-launch date.
On October 14, Beck announced that Neutron’s inaugural flight would move into 2027 after manufacturing problems affected the carbon-composite propellant dome on the first-stage tank.
During the update, Beck explained that inspectors had found voids, or small air pockets, within the carbon-fiber layers of a newly cured forward dome. The company reproduced the problem during testing and adjusted its manufacturing process. A subsequent aft dome produced using the revised method was described by Beck as the highest-quality carbon-composite dome the company had manufactured.
However, Rocket Lab still needs to manufacture and inspect a replacement forward dome before assembling the complete first stage. Hydrostatic and cryogenic testing must follow. Beck said the company expected the first two steps to be completed before the first quarter of 2027, with the remaining assembly and testing work completed during that quarter, assuming progress stays on schedule.
He deliberately avoided committing to another launch date, saying: “I’d rather show you real-time progress than give you a date that I might have to walk back.”
That statement sets up a clear question for Monday’s call. Investors will want to know whether the manufacturing and testing milestones remain on schedule and whether management has gained enough visibility to narrow the launch window. A more specific date would provide greater visibility, but the company has so far made clear that it wants to complete the necessary engineering work before committing to another target.
FinanceFeeds covered the original setback in its October 15 report on Rocket Lab stock falling after the Neutron delay to 2027, including the subsequent reductions in price targets from KeyBanc and Clear Street.
What Investors Need From Rocket Lab’s Q3 Call
Beyond the headline revenue figure, the call will test whether Rocket Lab can maintain the momentum of its existing launch and space systems operations while Neutron remains in development. The $2.36 billion backlog reported in June provides substantial contracted business visibility, but investors will want more information about the timing of deliveries, contract execution and the contribution of the different business segments.
Management’s comments on the Iridium acquisition will also remain relevant. Rocket Lab announced the transaction as part of its broader ambition to become a vertically integrated space company, combining spacecraft manufacturing, launch services and satellite communications. The acquisition adds another layer to the company’s investment and execution requirements.
For Neutron, the most useful information would be confirmation that the replacement forward dome is progressing through manufacturing and inspection, alongside a clearer timetable for first-stage assembly and qualification testing. Investors should distinguish those engineering milestones from an actual launch commitment.
Rocket Lab’s Friday and Monday share-price advances show that investors are entering the results announcement with renewed buying interest. But the earnings report will need to support the optimism with continued revenue growth, controlled operating losses and tangible progress on Neutron. A new launch date would help narrow one of the company’s largest execution uncertainties, although the more important milestone remains demonstrating that the rocket can complete testing and reach its first flight reliably.
